Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,800
Closed -$177K 3029
2020
Q2
$177K Sell
10,800
-3,200
-23% -$48.7K ﹤0.01% 2676
2020
Q1
$127K Sell
14,000
-10,100
-42% -$203K ﹤0.01% 2795
2019
Q4
$512K Buy
+24,100
New +$535K ﹤0.01% 2779
2019
Q3
Sell
-29,600
Closed -$718K 3399
2019
Q2
$718K Buy
+29,600
New +$609K ﹤0.01% 2214
2018
Q4
Sell
-6,600
Closed -$259K 2916
2018
Q3
$259K Sell
6,600
-1,400
-18% -$63.1K ﹤0.01% 2855
2018
Q2
$394K Sell
8,000
-17,000
-68% -$965K ﹤0.01% 2778
2018
Q1
$1.49M Buy
25,000
+22,000
+733% +$1.47M 0.01% 1737
2017
Q4
$236K Buy
+3,000
New +$242K ﹤0.01% 2839

Other funds holding ADNT

John Overdeck's ADNT Position: Q2 2026 in Review

John Overdeck reduced its Adient (ADNT) stake by 77% in Q2 2026, selling an estimated $11.8M and leaving 163,398 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

John Overdeck first reported a position in ADNT in Q4 2016 and has held it in 29 quarters since. The position peaked at $25.9M in Q3 2017. 311 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • John Overdeck held 163,398 shares of Adient worth $3M as of Q2 2026.
  • John Overdeck sold 552,931 Adient shares in Q2 2026, an estimated $11.8M.
  • Adient made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2626 holding.
  • John Overdeck first reported a position in Adient in Q4 2016 and has held it in 29 quarters since.
  • John Overdeck's Adient position peaked at $25.9M in Q3 2017.
  • 311 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.